Dare Bioscience (DARE) Accumulated Expenses (2016 - 2025)
Historic Accumulated Expenses for Dare Bioscience (DARE) over the last 11 years, with Q3 2025 value amounting to $2.3 million.
- Dare Bioscience's Accumulated Expenses rose 2561.34% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 2561.34%. This contributed to the annual value of $3.0 million for FY2024, which is 532.75% up from last year.
- Latest data reveals that Dare Bioscience reported Accumulated Expenses of $2.3 million as of Q3 2025, which was up 2561.34% from $2.5 million recorded in Q2 2025.
- In the past 5 years, Dare Bioscience's Accumulated Expenses registered a high of $10.9 million during Q4 2022, and its lowest value of $1.3 million during Q2 2024.
- Moreover, its 5-year median value for Accumulated Expenses was $3.1 million (2021), whereas its average is $3.7 million.
- Its Accumulated Expenses has fluctuated over the past 5 years, first surged by 24735.87% in 2022, then tumbled by 7499.24% in 2024.
- Dare Bioscience's Accumulated Expenses (Quarter) stood at $3.1 million in 2021, then surged by 247.36% to $10.9 million in 2022, then plummeted by 73.48% to $2.9 million in 2023, then increased by 5.33% to $3.0 million in 2024, then fell by 23.6% to $2.3 million in 2025.
- Its Accumulated Expenses was $2.3 million in Q3 2025, compared to $2.5 million in Q2 2025 and $1.8 million in Q1 2025.